Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 2 Interventional Results available

Study of Magrolimab in Patients With Solid Tumors

ClinicalTrials.gov ID: NCT04827576

Public ClinicalTrials.gov record NCT04827576. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 3, 2026, 1:04 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2, Multi-Arm Study of Magrolimab in Patients With Solid Tumors

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The goals of this clinical study are to learn about the safety, tolerability, dosing and effectiveness of magrolimab in combination with docetaxel in participants with solid tumors.

Study identification

NCT ID
NCT04827576
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 2
Lead sponsor
Gilead Sciences
Industry
Enrollment
106 participants

Conditions and interventions

Conditions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 30, 2021
Primary completion
Sep 30, 2024
Completion
Sep 30, 2024
Last update posted
May 7, 2025

2021 – 2024

United States locations

U.S. sites
21
U.S. states
16
U.S. cities
20
Facility City State ZIP Site status
Cancer Treatment Centers of America Goodyear Arizona 85338
UC San Diego Moores Cancer Center La Jolla California 92093
Providence Saint John's Health Center Santa Monica California 90404
St. Jude Hospital Yorba dba St. Joseph Heritage Healthcare Santa Rosa California 95403
University of Miami Deerfield Beach Florida 33064
Tallahassee Memorial Healthcare Cancer Center Tallahassee Florida 32308
University Center and Blood Center,LLC. Athens Georgia 30607
Southeastern regional Medical Center Newnan Georgia 30265
Saint Alphonsus Cancer Institute Caldwell Caldwell Idaho 83605
Orchard Healthcare Research Inc Skokie Illinois 60077
University of Iowa Hospitals & Clinics Iowa City Iowa 52242
University of Michigan Ann Arbor Michigan 48109
Virginia Piper Cancer Center (Alliant Health) Saint Paul Minnesota 55102
Comprehensive Cancer Centers of Nevada- Twain Office Las Vegas Nevada 89169
Astera Cancer Care East Brunswick New Jersey 08816
Oregon Health & Science University Portland Oregon 97239
Charleston Oncology Charleston South Carolina 29414
Mary Crowley Cancer Research Dallas Texas 75230
MD Anderson Cancer Center Dallas Texas 77030
Huntsman Cancer Institute, University of Utah Salt Lake City Utah 84112
Medical Oncology Associates,PS (dba Summit Cancer Center) (includes IP Shipment) Spokane Washington 99208

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 28 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04827576, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 7, 2025 · Synced Sep 3, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT04827576 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →